Medtronic Plc

Medtronic Plc

MDT

Market Cap$106.43B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Medtronic PlcMedtronic Plc253.37%9%3.40.6

Earnings Call Q4 2025

May 21, 2025 - AI Summary

Strong Q4 Performance: Medtronic reported Q4 revenue of $8.9 billion, growing 5.4% organically year-over-year. EPS rose 11% to $1.62, with the company achieving mid-single-digit revenue growth for 2.5 years consecutively, demonstrating the durability of its growth drivers.
Separation of Diabetes Business: Medtronic announced a planned spin-off of its Diabetes business into a standalone public company through an IPO and subsequent share exchange. This separation aims to sharpen focus on high-margin growth markets and is expected to enhance Medtronic’s overall margins and profitability.
Guidance for Fiscal Year 2026: The company anticipates approximately 5% organic revenue growth for FY26, with a projection of EPS growth of around 4%, excluding tariff impacts. This reflects ongoing confidence in key growth areas but factors in potential external challenges.

Exclusive for Stockcircle Pro members

Sign upSign Up
$119.24

Current Fair Value

39.3% upside

Undervalued by 39.3% based on the discounted cash flow analysis.

Share Statistics

Market cap$106.43 Billion
Enterprise Value$132.92 Billion
Dividend Yield$2.8 (3.37430706194264%)
Earnings per Share$2.77
Beta0.83
Outstanding Shares1,282,400,000

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio24.98
PEG-1179.4
Price to Sales3.42
Price to Book Ratio2.25
Enterprise Value to Revenue4
Enterprise Value to EBIT28.63
Enterprise Value to Net Income31
Total Debt to Enterprise0.21
Debt to Equity0.56

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Medtronic Plc

CEO: Geoffrey Martha